
We are a specialty biopharmaceutical company engaged in the development and commercialization pharmaceutical and diagnostic products. $CSCI
Edmonton, Alberta
Joined May 2015
- Tweets608
- Following191
- Followers2.6K
- Likes8
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
bit.ly/4jnlwdH
$CSCI
303
COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders
bit.ly/45qgZnm
$CSCI
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
bit.ly/44yekI5
$CSCI #Therapeutics
104
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
bit.ly/3G89sPL
$CSCI #therapeutics
89
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
bit.ly/3YpZnDP
$CSCI #Therapeutics
62
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
bit.ly/41L14g4
$CSCI #CoSciencs
Advancing a Priority Pipeline Beyond Successful Base-Business
$CSCI #CoSciencs
173
Transforming Health Through Natural Based Products
$CSCI #CoSciencs
185
Wishing you a #HappyNewYear filled with joy, new beginnings, and endless opportunities. Here’s to making 2025 your best year yet!
79
Stay in the loop with Cosciencs! Sign up for alerts and be the first to know about our latest updates.
bit.ly/3AvH2vY
#CoSciencs $CSCI
65
We are focused on leveraging our research and clinical development expertise to advance medicines that improve the quality of life of patients with significant unmet medical needs across a range of therapeutic areas.
$CSCI #CoSciencs
1
98
Establishing #COSCIENS as a global leader in the development and commercialization of therapeutic assets that have the potential to enhance the lives of patients in need.
bit.ly/408fOVJ
$CSCI
55
Wishing you a peaceful and joyful holiday season.
#HappyHolidays
44
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
bit.ly/4fCRwbL
$CSCI #Therapeutics
57
We are a specialty biopharmaceutical company dedicated to advancing health and wellness through our innovative portfolio of cosmeceutical, nutraceutical, and pharmaceutical products.
bit.ly/408fOVJ
50
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
bit.ly/3AGJIrd
$CSCI #Diagnostics #Therapeutics
47
COSCIENS Biopharma Announces Change to Board of Directors
bit.ly/4eUMFCO
$CSCI #Diagnostics #Therapeutics
63
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
bit.ly/3ZInjnB
$CSCI #Diagnostics #Therapeutics
67
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
bit.ly/3MU1sSj
$CSCI #Diagnostics #Therapeutics
65
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
bit.ly/4dCNBLT
$CSCI #Therapeutics
1
86



















